Yingmei Fu

Prof. Yingmei Fu


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 September 2015 in Tropical Medicine & International Health
Verified
Journal Article
Open access
PDF file
JGJiarui Gu
Jiarui Gu
JZJizi Zhao
Jizi Zhao
YHYing Huang
Ying Huang
WYWeidong Yang
Weidong Yang
ZRZheng Ren
Zheng Ren
YFYingmei Fu
Yingmei Fu
Objective: To identify and compare the factors affecting the knowledge of, attitude towards and use of antibiotics between urban and rural residents in China.Methods: A total of 3631 urban and rural residents in Heilongjiang Province, China, were selected using random sampling. Questionnaires recorded demographic characteristics and participant knowledge of, attitude towards and use of antibiotics. The responses of rural and urban residents were compared, and logistic regression analysis was applied to identify the factors that may contribute to the knowledge of, attitude towards and use of antibiotics.Results: The majority of the participants (>60%) were aware that antibiotics could be used to treat bacterial infections and that bacteria could be resistant to antibiotics. However, only roughly half (40–60%) of the participants were aware that bacterial resistance to antibiotics had become a problem in China. Urban participants reported a more adequate knowledge of, attitude towards and use of antibiotics than rural participants. Logistic regression analysis indicated that urban residency, female gender and level of education were associated with knowledge of, attitude towards and use of antibiotics.Conclusions: Within our sample in Heilongjiang Province, the knowledge of, attitude towards and use of antibiotics were suboptimal in roughly half of all urban and rural residents, but better in urban than in rural residents. Targeted interventions to educate rural residents in particular may reduce the misuse of antibiotics.

1 July 2021 in Tuberculosis
Verified
Journal Article
Closed access
XHXue Han
Xue Han
TLTing Li
Ting Li
YFYunfan Fan
Yunfan Fan
XWXinyang Wang
Xinyang Wang
WGWei Gu
Wei Gu
YFYingmei Fu
Yingmei Fu

19 February 2025 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
WGWei Gu
Wei Gu
ZHZhigang Huang
Zhigang Huang
YFYunfan Fan
Yunfan Fan
TLTing Li
Ting Li
XYXinyuan Yu
Xinyuan Yu
YFYingmei Fu
Yingmei Fu
Tuberculosis (TB) is a major global health issue. Early diagnosis of TB is still a challenge. Studies are seeking non-sputum biomarker-based TB test. Emerging evidence indicates potential significance of blood microbiome signatures for diseases. However, blood microbiome RNA profiles are unknown in TB. We aimed to characterize the blood microbiome of TB patients and identify Mycobacterium tuberculosis (Mtb) genome-derived small RNA molecules to serve as diagnostic biomarkers for TB. RNA sequencing data of the blood from TB patients and healthy controls were retrieved from the NCBI-SRA database for analyzing the blood microbiome and identifying rRNA-derived small RNA (rsRNA) of Mtb. Small RNA-seq was performed on plasma exosomes from TB patients and healthy controls. The levels of the candidate Mtb rsRNAs were determined by real-time quantitative reverse transcription PCR (RT-qPCR) on plasma from a separate cohort of 73 TB patients and 62 healthy controls. The blood microbiome of TB patients consisted of RNA signals from bacteria, fungi, archaea, and viruses, with bacteria accounting for more than 97% of the total. Reduced blood microbial diversity and abundance of 6 Mycobacterium-associated bacterial genera, including Mycobacterium, Priestia, Nocardioides, Agrobacterium, Bradyrhizobium, and Escherichia, were significantly altered in the blood of TB patients. A diagnostic model for TB based on the 6 genera achieved an area under the curve (AUC) of 0.8945. rsRNAs mapped to the Mtb genome were identified from blood and plasma exosomes of TB patients. RT-qPCR results showed that 2 Mtb-derived rsRNAs, 16 S-L1 and 16 S-L2, could be used as diagnostic biomarkers to differentiate TB patients from healthy controls, with a high co-diagnostic efficacy (AUC = 0.7197). A panel of blood microbiome signatures and Mtb-derived rsRNAs can serve as blood biomarkers for TB diagnosis.

20 July 2022 in Epidemiology and Infection
Verified
Journal Article
Open access
PDF file
WAWadee Abdullah AL-shehari
Wadee Abdullah AL-shehari
YYYi-An Yin
Yi-An Yin
XWXinyang Wang
Xinyang Wang
YWYing Wang
Ying Wang
HSHaobo Sun
Haobo Sun
FZFengmin Zhang
Fengmin Zhang
Tuberculosis is a major public health issue in Yemen, a country located at the southwestern tip of the Arabian Peninsula, while the situation of tuberculosis had been further exacerbated since the war started in 2015. The objective of this study is to investigate the incidence of tuberculosis in Yemen before the outbreak of COVID-19, from 2006 to 2018. During the 13-year period, 92 482 patients were enrolled in the TB programme records from the 22 governorates. Almost equal number of cases were diagnosed between males and females (a male to female ratio, 1.03:1). A notable rising incidence was observed in all age groups starting from 2011. The sharpest increase occurred in children under age 15, rising by 8.0-fold from 0.5 in the period 2006–2010 to 4.1 in the period 2011–2018. Paediatric TB accounted for 9.6% of all reported cases. In terms of the patient residence, incidence has more than doubled in Sana'a city, Sana'a Gov., Hajjah and Saadah. Concomitant diseases with tuberculosis included diabetes mellitus (14.0%), brucellosis (6.1%), hepatitis (6.0%), rheumatoid arthritis (4.3%), renal disorders (2.5%) and HIV infection (2.5%). Development of interventions to reduce tuberculosis incidence in children and concomitant communicable diseases is urgently needed.

10 June 2024 in Clinica Chimica Acta
Verified
Journal Article
Closed access
SJSadia Jabeen
Sadia Jabeen
NANiaz Ahmed
Niaz Ahmed
FRFaiqa Rashid
Faiqa Rashid
NLNand Lal
Nand Lal
FKFanhui Kong
Fanhui Kong
FZFengmin Zhang
Fengmin Zhang

1 May 2022 in Microbial Drug Resistance
Verified
Journal Article
Closed access
RSRui Sun
Rui Sun
XZXianqi Zhao
Xianqi Zhao
QMQingtai Meng
Qingtai Meng
PHPing Huang
Ping Huang
QZQian Zhao
Qian Zhao
YFYingmei Fu
Yingmei Fu
The global emergence of antibiotic resistance, especially in Gram-negative bacteria, is an urgent threat to public health. Inevitably, considering its extensive use and misuse, resistance toward ciprofloxacin has increased in almost all clinically relevant bacteria. This study aimed to investigate the transcriptome changes at a high concentration of ciprofloxacin in Escherichia coli . In brief, 1,418 differentially expressed genes (DEGs) were identified, from which 773 genes were upregulated by ciprofloxacin, whereas 651 genes were downregulated. Enriched biological pathways reflected the upregulation of biological processes such as DNA damage and repair system, toxin/antitoxin systems, formaldehyde detoxification system. With kyoto encyclopedia of genes and genomes pathway analysis, higher expressed DEGs were associated with “LPS biosynthesis,” “streptomycin biosynthesis,” and “polyketide sugar unit biosynthesis.” Lower expressed DEGs were associated with “biosynthesis of amino acids” and “flagellar assembly” pathways. After treatment of ciprofloxacin, lipopolysaccharide (LPS) release was increased by two times, and the gene expression level of LPS synthesis was elevated ( p < 0.05) in both reference and clinical strains. Our results demonstrated that transient exposure to high-dose ciprofloxacin is a double-edged sword. Cautions should be taken when administering high-dose antibiotic treatment for infectious diseases.